Franklin Resources
CNTX icon

Franklin Resources’s Context Therapeutics CNTX Stock Holding History

Franklin Resources’s Portfolio CNTX Stock Details CNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.11M Hold
3,803,338
– – ﹤0.01% 1983
2026
Q1 		$9.96M Sell
3,803,338
-200,042
-5% -$467K ﹤0.01% 1245
2025
Q4 		$5.88M Hold
4,003,380
– – ﹤0.01% 1336
2025
Q3 		$3.88M Hold
4,003,380
– – ﹤0.01% 1526
2025
Q2 		$2.62M Hold
4,003,380
– – ﹤0.01% 1614
2025
Q1 		$2.45M Hold
4,003,380
– – ﹤0.01% 1614
2024
Q4 		$4.2M Buy
4,003,380
+2,149,392
+116% +$3.72M ﹤0.01% 1422
2024
Q3 		$3.69M Buy
+1,853,988
New +$4.11M ﹤0.01% 1490

Other funds holding CNTX

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Franklin Resources's CNTX Position: Q2 2026 in Review

Franklin Resources held its Context Therapeutics (CNTX) position steady in Q2 2026 at 3,803,338 shares worth $2.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1983.

Franklin Resources first reported a position in CNTX in Q3 2024 and has held it in 8 quarters since. The position peaked at $9.96M in Q1 2026. 43 funds tracked by Wall St. Rank hold CNTX as of Q2 2026.

  • Franklin Resources held 3,803,338 shares of Context Therapeutics worth $2.11M as of Q2 2026.
  • Franklin Resources left its Context Therapeutics share count unchanged in Q2 2026.
  • Context Therapeutics made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #1983 holding.
  • Franklin Resources first reported a position in Context Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • Franklin Resources's Context Therapeutics position peaked at $9.96M in Q1 2026.
  • 43 funds tracked by Wall St. Rank held Context Therapeutics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.